Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
Market capitalization of Oramed Pharmaceuticals (ORMP)
Market cap: $93.44 Million
As of May 2024 Oramed Pharmaceuticals has a market cap of $93.44 Million. This makes Oramed Pharmaceuticals the world's 7478th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Oramed Pharmaceuticals from 2008 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $93.44 M | 0.28% |
| 2023 | $93.18 M | -80.2% |
| 2022 | $0.47 B | -13.65% |
| 2021 | $0.54 B | 439.74% |
| 2020 | $0.10 B | 12.66% |
| 2019 | $89.61 M | 71.89% |
| 2018 | $52.13 M | -59.51% |
| 2017 | $0.12 B | 58.58% |
| 2016 | $81.2 M | -18.15% |
| 2015 | $99.2 M | 101.2% |
| 2014 | $49.3 M | -59.8% |
| 2013 | $0.12 B | 329.6% |
| 2012 | $28.54 M | 45.43% |
| 2011 | $19.62 M | 11.36% |
| 2010 | $17.62 M | -31.31% |
| 2009 | $25.66 M | 16.55% |
| 2008 | $22.01 M |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Oramed Pharmaceuticals was reported to be:
$93.44 Million
$93.44 Million
$93.44 Million
$94.66 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $588.39 B | 629,557.68% | 🇩🇰 Denmark |
 Sanofi SNY | $122.00 B | 130,466.56% | 🇫🇷 France |
 Ultragenyx RARE | $3.48 B | 3,624.90% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.63 B | 584.71% | 🇺🇸 USA |
 Compugen CGEN | $0.19 B | 105.42% | 🇮🇱 Israel |